>>> US After Hours Summary: NVAX +5.7% higher on positive vaccine news; SGMS jum

After Hours Summary: NVAX +5.7% higher on positive vaccine news; SGMS jumps +8.6% after it withdraws offer for SCPL -19%; NKLA +5.6% higher on tweet showing first customer delivery

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: None

Companies trading higher in after hours in reaction to news: SGMS +8.6% (SGMS withdraws all-stock offer to acquire remaining 19% interest in SCPL), NVAX +5.7% (two-dose of NVX-CoV2373 demonstrated cross-reactive immune responses against Omicron), NKLA +5.6% (co tweets showing its first customer delivery), ARQT +1.5% (FDA accepts review of NDA for roflumilast cream for psoriasis; PDUFA date is July 29), DK +0.7% (DK announces partial sale program of units in DKL), DKL +0.5% (DK announces partial sale program of units in DKL), ALNY +0.3% (FDA approves Leqvio), DOLE +0.1% (voluntarily recalls salads produced at two facilities)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: AVO -9.5%

Companies trading lower in after hours in reaction to news: SCPL -19.2% (SGMS withdraws all-stock offer to acquire remaining 19% interest in SCPL), ROIV -1.7% (stock offering), KREF -1.6% (files mixed securities shelf offering; also files for 17.75 mln share offering by selling shareholders), RKLB -1.2% (to redeem all outstanding public warrants), TEVA -0.5% (announces launch of first-to-market generic version of Narcan in the US), AEM -0.3% (provides update related to COVID-19 cases at Nunvaut operations), GILD -0.2% (announces publication of results from Phase 3 study of remdesivir in the NEJM), WEN -0.1% (files mixed securities shelf offering), CDRE -0.1% (stock offering)